Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors
- PMID: 3524805
Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors
Abstract
A monoclonal antibody to human estrogen receptor protein (H222 Sp gamma), amplified via immunoperoxidase techniques, was used in the analysis of estrogen receptor in 452 breast carcinomas, 100 endometrial carcinomas, and 15 melanomas. Immunohistochemical evaluation incorporated both intensity and distribution of staining (HSCORE). Quantitative estrogen receptor content was determined by dextran-coated charcoal analysis and sucrose density gradient analysis. In all cases H222 Sp gamma localized in the nucleus of target cells. A semiquantitative correlation existed between HSCORE and biochemical assays for breast and endometrial tissues. The sensitivities and specificities for HSCORE as compared to the biochemical assays ranged from 80 to 95% and from 74 to 94%, respectively. HSCORE correlated with tumor grade for breast and endometrial carcinoma. Immunohistochemical evaluation showed no specific staining in melanomas. The data suggest that immunohistochemical receptor localization provides information complementary to standard biochemical assays in the tissues studied.
Similar articles
-
Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody.Cancer Res. 1986 Oct;46(10):5419-25. Cancer Res. 1986. PMID: 3756890
-
Estrogen receptor immunocytochemical assay (ER-ICA): computerized image analysis system, immunoelectron microscopy, and comparisons with estradiol binding assays in 115 breast carcinomas.Cancer Res. 1986 Aug;46(8 Suppl):4271s-4277s. Cancer Res. 1986. PMID: 3524808
-
Absence of estrogen receptor in human melanoma as evaluated by a monoclonal antiestrogen receptor antibody.Arch Dermatol. 1987 Jun;123(6):764-5. Arch Dermatol. 1987. PMID: 3555354
-
Estrogen receptors in breast cancer.J Fla Med Assoc. 1988 Jan;75(1):22-8. J Fla Med Assoc. 1988. PMID: 3279159 Review. No abstract available.
-
Receptor measurements.Clin Lab Med. 1984 Dec;4(4):817-33. Clin Lab Med. 1984. PMID: 6210172 Review.
Cited by
-
Biomarkers for efficacy of adjuvant chemotherapy following complete resection in NSCLC stages I-IIIA.Eur Respir Rev. 2015 Jun;24(136):340-55. doi: 10.1183/16000617.00005814. Eur Respir Rev. 2015. PMID: 26028645 Free PMC article. Review.
-
TMA Navigator: Network inference, patient stratification and survival analysis with tissue microarray data.Nucleic Acids Res. 2013 Jul;41(Web Server issue):W562-8. doi: 10.1093/nar/gkt529. Epub 2013 Jun 12. Nucleic Acids Res. 2013. PMID: 23761446 Free PMC article.
-
Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer.Ann Oncol. 2013 Jul;24(7):1792-1801. doi: 10.1093/annonc/mdt066. Epub 2013 Feb 28. Ann Oncol. 2013. PMID: 23448807 Free PMC article. Clinical Trial.
-
Alteration of extracellular superoxide dismutase expression is associated with an aggressive phenotype of oral squamous-cell carcinoma.Exp Ther Med. 2010 Jul;1(4):585-590. doi: 10.3892/etm_00000092. Epub 2010 Jul 1. Exp Ther Med. 2010. PMID: 22993580 Free PMC article.
-
Quantification of HER1, HER2 and HER3 by time-resolved Förster resonance energy transfer in FFPE triple-negative breast cancer samples.Br J Cancer. 2020 Feb;122(3):397-404. doi: 10.1038/s41416-019-0670-8. Epub 2019 Dec 3. Br J Cancer. 2020. PMID: 31792349 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical